List of Excipients in API olanzapine and samidorphan l-malate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olanzapine and samidorphan l-malate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | CELLULOSE, MICROCRYSTALLINE | 2031-08-30 |
| Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | CROSPOVIDONE | 2031-08-30 |
| Alkermes Inc | LYBALVI | olanzapine and samidorphan l-malate | 65757-651 | FERRIC OXIDE YELLOW | 2031-08-30 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for olanzapine and samidorphan l-malate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olanzapine and samidorphan l-malate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
olanzapine and samidorphan l-malate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
olanzapine and samidorphan l-malate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
olanzapine and samidorphan l-malate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
olanzapine and samidorphan l-malate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
olanzapine and samidorphan l-malate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
olanzapine and samidorphan l-malate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
olanzapine and samidorphan l-malate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
olanzapine and samidorphan l-malate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Alkermes Inc | olanzapine and samidorphan l-malate | 65757-651 |
| >Company | >Ingredient | >NDC |
olanzapine and samidorphan l-malate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch